Table 2.
Hematological profiles for patients with primary DENV infections.
| Dengue 1 | Dengue 2 | Dengue 3 | Dengue 4 | |||||
|---|---|---|---|---|---|---|---|---|
| Mean (range) | OR (95% CI) | Mean (range) | OR (95% CI) | Mean (range) | OR (95% CI) | Mean (range) | OR (95% CI) | |
| N (%) | N (%) | N (%) | N (%) | |||||
| AST (IU/L) | 228 (59–406) | 2.0 (0.19 20.14) | 139 (27-570) | 0.75 (0.13–4.09) | 114 (41–288) | 0.83 (0.12–5.47) | Sample size too small | |
| 6 (86%) | 12 (75%) | 6 (50%) | ||||||
| ALT (IU/L) | 101 (20–247) | 1.86 (0.38–8.98) | 146 (16–751) | 0.83 (0.25–2.72) | 83.3 (28–277) | 0.75 (0.17–3.29) | 86.2 (28–221) | 1.0 (0.12–7.81) |
| 5 (62%) | 11 (48%) | 4 (33%) | 1 (16.6%) | |||||
| TLC (109/L) | 41 (12.9–52.7) | 1.39 (0.3–6.41) | 30 (4–55.5) | 0.56 (0.2–1.56) | 27.1 (8.2–48.1) | 2.89 (0.7–11.87) | 15.8 (3.5–24.1) | 0.51 (0.07–3.27) |
| 5 (62%) | 19 (46%) | 9 (75%) | 1 (20%) | |||||
| Platelets (109/L) | 46.5 (12-133) | 546E+006 | 119 (19–330) | 370E+015 | 134 (3–258) | 0.94 (0.24–3.57) | 114 (43–204) | 2.0 (0.2–19.09) |
| 8 (100%) | 23 (57%) | 8 (67%) | 4 (80%) | |||||
| Hemoglobin (gm/dL) | 15.4 (12.2–17.2) | 7.14E−009 | 13.5 (9.2–17.4) | 1.81 (0.33–9.89) | 13.5 (10.5–18.1) | 1.43 (0.25–8.18) | 13.8 (12.1–14.8) | 7.14E−009 |
| 0 (0%) | 6 (16%) | 2 (14%) | 0 (0%) | |||||
| Hematocrit | 44.8 (36–48.2) | 0.10 0.009–1.09 | 39.2 (32.7–46.9) | 1.04 (0.23–4.7) | 37.5 (31.4–42.8) | 2.0 (0.18–22.05) | 40.2 (36.6–42.6) | 629E+006 |
| 0 (0%) | 10 (62%) | 3 (75%) | 1 (25%) | |||||
These patients were NS1 and RT-PCR positive for only one serotype and negative for DENV neutralizing antibodies via PRNT. Bold font indicates statistical significance. OR, odds ratio; CI, confidence interval; N, number of patients.